References
- Kahn JO, Northfelt DW, Miles SA. AIDS-associated Kaposi's sarcoma. In: Volberding P, Jacobson MA, eds. AIDS clinical review: 1992. New York: Dekker, 1992; 263–76
- Ober WB. Kaposi: the man and the sarcoma. In: Gottlieb GJ, Ackerman AB, eds. Kaposi's sarcoma: a text and atlas. Philadelphia: Lea & Febiger, 1988; 14
- Soave R, Sepkowitz KA. The immunocom promised host. In: Reese RE, Betts RF, eds. A practical approach to infectious diseases. 3d ed. Boston: Little, Brown, 1991; 598
- Harwood AR, Osoba D, Hofstader SL, et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979; 67(5): 759–65
- Ackerman AB, Gottlieb GJ. Atlas of the gross and microscopic features. In: Gottlieb, Ackerman, eds,2 pp 29–72
- Templeton AC. Pathology. In: Ziegler JL, Dorfman RF, eds. Kaposi's sarcoma: pathophysiology and clinical management. New York: Dekker, 1988; 23–66
- Volberding PA. Clinical features and staging. In: Ziegler, Dorfman, eds,6 pp 169–84
- Gottlieb GJ, Ackerman AB. Atlas of the gross and microscopic features of simulators. In: Gottlieb, Ackerman, eds,2 pp 73–6
- Koehler JE, Quinn FD, Berger TG, et al. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327(23): 1625–31
- Taylor J, Afrasiabi R, Fahey JL, et al. Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma. Blood 1986; 67(3): 666–71
- Amazon K, Rywlin AM. Systemic manifestations. In: Gottlieb, Ackerman, eds,2 p 113
- Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 1989; 7(9): 1201–7
- Kahn J, Volberding P. New insights into the pathogenesis and treatment of AIDS-associated Kaposi's sarcoma. In: Groopman JE, Chen IS, Essex M, et al, eds. Human retroviruses: proceedings of a Chimertech-UCLA Symposium held at Tamarron, Colorado, February 4–11, 1989. New York: Wiley-Liss, 1990; 337–46
- Harris JW, Berson AM, Reed TA, et al. Radiation therapy for Kaposi's sarcoma in AIDS. In: Ziegler, Dorfman, eds,6 p 243
- Tappero JW, Berger TG, Kaplan LD, et al. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial. J Acquir immune Defic Syndr 1991; 4(9): 839–46
- Conant MA, Galzagorry G, Illeman M. Intralesional vinblastine (Velban) treatment of lesions of Kaposi's sarcoma. (Abstr) Proceedings, Fifth International Conference on AIDS. Montreal: 1989 Jun 6: 335
- Abrams DI, Volberding PA. Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol 1986; 13(3 Suppl 2): 43–7
- Krown SE, Gold JW, Niedzwiecki D, et al. Interferon-α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990; 112 (11): 812–21 [erratum, Ann Intern Med 1990; 113(4): 334]
- Hochster H, Liebes L, Chachoua A, et al. Phase I study and pharmacokinetics of weekly doxorubicin (dox) and AZT in Kaposi's sarcoma (KS). (Abstr) Proceedings, Fourth International Conference on AIDS. Stockholm: 1988 Jun: 175